We are Stibbe,
Public Law specialists
Litigation and Dispute Resolution specialists
Insolvency and Restructuring specialists
Capital Markets specialists
Employment and Benefits specialists
Pensions specialists
Corporate and M&A specialists
Projects specialists
Environment and Planning specialists
Procurement Law specialists
Tax specialists
Corporate Fraud and Criminal Law specialists
Intellectual Property specialists
Real Estate and Construction specialists
Information Technology specialists
Banking and Finance specialists
Supreme Court specialists
Data Protection specialists
Insurance and Reinsurance specialists
Compliance and Sanctions specialists
Foreign Investments specialists
Investment Management specialists
EU Law, Competition and Regulation specialists
Practice areas

Our people

No results found

Latest news & insights

Recent events

Recent publications

25.10.2016 EU law
A cautionary tale - EU merger control rules may apply to pharma pipeline products

Articles - In Case M.7872 – Novartis/GlaxoSmithKline (ofatumumab autoimmune indications), the European Commission claimed jurisdiction under the merger control rules over a transaction by virtue of which a yet to be fully developed biological drug was transferred to a purchaser. In applying the relevant jurisdictional test, the Commission made a series of observations which have far-reaching implications. 

Our locations

Our website uses cookies: third party analytics cookies to best adapt our website to your needs & cookies to enable social media functionalities. For more information on the use of cookies, please check our Privacy and Cookie Policy. Please note that you can change your cookie opt-ins at any time via your browser settings.

Privacy and Cookie Policy